Collaborative research between the University of Kentucky (UK) and University of Southern California (USC) suggests that a noninvasive neuroimaging technique may index early-stage blood-brain barrier (BBB) dysfunction associated with small vessel disease (SVD). Cerebral SVD is the most common cause of vascular cognitive impairment, with a significant proportion of cases going on to develop dementia.
New urine test could detect aggressive form of prostate cancer often missed by as many as one in five diagnostic scans The University of Michigan Rogel Cancer Center has developed a new test called Urine Prostate Seq test (UPSeq) It analyzes 15 specific strands of RNA together and looks for specific genes that are ‘overexpressed’
(HealthDay)—The T-Detect COVID Test, a T cell-based test that helps to identify individuals with recent or prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, was granted emergency use authorization, the U.S. Food and Drug Administration announced Friday. The next-generation sequencing-based test analyzes DNA sequences to identify those with an adaptive T cell immune response
Breast cancer is the most frequently diagnosed cancer in women, and metastasis from the breast to other areas of the body is the leading cause of death in these patients. Detecting circulating tumor cells (CTCs) in the bloodstream could help doctors find and treat metastases at an earlier stage, increasing chances of survival. Now, researchers
People with COVID-19 who are asymptomatic can spread the disease without any outward signs that they’re sick. But a newly developed AI, with a keen algorithmic ear, might be able to detect asymptomatic cases from the sounds of people’s coughs, according to a new study. A group of researchers at MIT recently developed an artificial
A new machine learning-based online tool developed by researchers at Massachusetts General Hospital (MGH), Harvard Medical School (HMS), Georgia Tech and Boston Medical Center allows for early detection of COVID-19 outbreaks in different U.S. counties. The COVID-19 Outbreak Detection Tool is updated two-to-three times per week and it predicts how fast an outbreak is spreading
Two different types of detectable antibody responses in SARS-CoV-2 (COVID-19) tell very different stories and may indicate ways to enhance public health efforts against the disease, according to researchers at The University of Texas MD Anderson Cancer Center. Antibodies to the SARS-CoV-2 spike protein receptor binding domain (S-RBD) are speculated to neutralize virus infection, while
Researchers from Istituto Italiano di Tecnologia (IIT) and University of Salento, both in Lecce, Italy, and Harvard Medical School in Boston have developed a new light-based method to capture and pinpoint the epicenter of neural activity in the brain. The approach, described in Nature Methods, lays the foundation for novel ways to map connections across
A team of researchers from Baylor University, with assistance from staff at the Massachusetts Eye and Ear Infirmary, Harvard Medical School and the Dana-Farber Cancer Institute has developed and tested a smartphone app that is able to detect “white eye” in children by analyzing stored photographs. In their paper published in the journal Science Advances,
New Kent-led research shows that popular mobile phone games could provide a new tool to help doctors spot early signs of cognitive decline, some of which may indicate the onset of serious conditions like dementia. Investigating the link between patterns of tap, swipe and rotational gestures during mobile game play and the users’ cognitive performance,
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center developed the test for early detection of Barrett’s esophagus that offers promise for preventing deaths from esophageal adenocarcinoma. The test involves a novel swallowable balloon device that samples the esophagus and a DNA assay that detects Barrett’s esophagus and esophageal
Researchers at the Johns Hopkins Kimmel Cancer Center have developed a simple new blood test that can detect the presence of seven different types of cancer by spotting unique patterns in the fragmentation of DNA shed from cancer cells and circulating in the bloodstream. In a proof-of-concept study, the test, called DELFI (DNA evaluation of
A new method of determining the sequence of molecules in DNA can be used to detect small fragments of cancerous genetic material in blood samples from lung cancer patients with a high degree of accuracy, according to new research published in the leading cancer journal Annals of Oncology today. Results from analyses of so-called “liquid
THURSDAY, Dec. 20, 2018 — A miniaturized optical coherence tomography (OCT) imaging needle can detect blood vessels intraoperatively in the human brain in vivo, according to a study published online Dec. 19 in Science Advances. Hari Ramakonar, M.B.B.S., from Sir Charles Gairdner Hospital in Nedlands, Australia, and colleagues developed an imaging needle that is able
Professor of Electronic Engineering Andrew Flewitt is working with researchers at the Cancer Research UK (CRUK) Cambridge Centre on a more accurate PSA blood test to detect prostate cancer. At present, the test has limitations for diagnosis and has to be sent off to central labs for the results, a process which can take up
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok